The highly selective and oral phosphoinositide 3-kinase delta (PI3K-δ) inhibitor roginolisib induces apoptosis in mesothelioma cells and increases immune effector cell composition-Reference-Cited by-同舟云学术

The highly selective and oral phosphoinositide 3-kinase delta (PI3K-δ) inhibitor roginolisib induces apoptosis in mesothelioma cells and increases immune effector cell composition

Published:2024-05 Issue: Volume:43 Page:101857
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Kalla Claudia,Ott German,Finotello Francesca,Niewola-Staszkowska Karolina,Conza Giusy Di^ORCID,Lahn Michael,van der Veen Lars^ORCID,Schüler Julia^ORCID,Falkenstern-Ge Roger,Kopecka Joanna^ORCID,Riganti Chiara^ORCID

Funder

Robert-Bosch Stiftung GmbH

Italian Association for Cancer Research

Publisher

Elsevier BV

Reference49 articles.

1. Chemotherapy treatment in malignant pleural mesothelioma: a difficult history;Cinausero;J. Thorac Dis.,2018

2. Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations;Bueno;Nat. Genet,2016

3. Heterogeneity in Immune Cell Content in Malignant Pleural Mesothelioma;Minnema-Luiting;Int. J. Mol. Sci.,2018

4. First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label phase 3 trial;Baas;Lancet,2021

5. First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743;Peters;Ann. Oncol.,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Signaling pathways in liver cancer: pathogenesis and targeted therapy;Molecular Biomedicine;2024-05-31

2. Targeted Therapy in Mesotheliomas: Uphill All the Way;Cancers;2024-05-22